Cargando…

Protective Effects of Pterostilbene on Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting NF-κB and Activating Nrf2/HO-1 Signaling Pathways

Pterostilbene (PTER) is a kind of stilbene compound with biological activity isolated from plants such as red sandalwood, blueberry and grape. It has anti-tumor, anti-bacterial, anti-oxidation and other pharmacological activities. However, the underlying mechanism of the protective effect of PTER on...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yong, Han, Zhen, Jiang, Aimin, Wu, Di, Li, Shuangqiu, Liu, Ziyi, Wei, Zhengkai, Yang, Zhengtao, Guo, Changming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901969/
https://www.ncbi.nlm.nih.gov/pubmed/33633565
http://dx.doi.org/10.3389/fphar.2020.591836
_version_ 1783654464475889664
author Zhang, Yong
Han, Zhen
Jiang, Aimin
Wu, Di
Li, Shuangqiu
Liu, Ziyi
Wei, Zhengkai
Yang, Zhengtao
Guo, Changming
author_facet Zhang, Yong
Han, Zhen
Jiang, Aimin
Wu, Di
Li, Shuangqiu
Liu, Ziyi
Wei, Zhengkai
Yang, Zhengtao
Guo, Changming
author_sort Zhang, Yong
collection PubMed
description Pterostilbene (PTER) is a kind of stilbene compound with biological activity isolated from plants such as red sandalwood, blueberry and grape. It has anti-tumor, anti-bacterial, anti-oxidation and other pharmacological activities. However, the underlying mechanism of the protective effect of PTER on lipopolysaccharide (LPS)-induced acute lung injury (ALI) remained not clarified. In this study, LPS was used to establish a mouse model of ALI. Bronchoalveolar lavage fluid (BALF) was collected for inflammatory cells, and the wet-to-dry weight ratio of the lungs was measured. The activities of myeloperoxidase (MPO), antioxidant indexes such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) and oxidation index such as malondialdehyde (MDA) in lung tissues of mice were measured by the corresponding kits. The levels of Cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), TNF-α, IL-6 and IL-1β in lung tissues of mice were detected by quantitative real-time polymerase chain reaction (qRT-PCR). The activities of Nrf2, HO-1, p-p65 and p-IκB were determined by western blotting. The results showed that the model of LPS-induced ALI was successfully replicated, and it was found that PTER could significantly improve the pathological degree of ALI such as sustained the integrity of the lung tissue structure, alleviated pulmonary interstitial edema and alveolar wall thickening, reduced infiltrated inflammatory cells. PTER could decrease the number of inflammatory cells and obviously inhibit the increase of W/D ratio caused by LPS. PTER could also significantly reduce LPS-induced MPO and MDA, and increase LPS-decreased SOD, CAT and GSH-Px in the lungs. In addition, it was also found that PTER has the ability to decrease LPS-induced production of COX-2, iNOS, TNF-α, IL-6 and IL-1β. The underlying mechanism involved in the protective effect of PTER on ALI were via activating Nrf2 and HO-1, and inhibiting the phosphorylation of p65 and IκB. These results suggested that PTER can protect LPS-induced ALI in mice by inhibiting inflammatory response and oxidative stress, which provided evidence that PTER may be a potential therapeutic candidate for LPS-induced ALI intervention.
format Online
Article
Text
id pubmed-7901969
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79019692021-02-24 Protective Effects of Pterostilbene on Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting NF-κB and Activating Nrf2/HO-1 Signaling Pathways Zhang, Yong Han, Zhen Jiang, Aimin Wu, Di Li, Shuangqiu Liu, Ziyi Wei, Zhengkai Yang, Zhengtao Guo, Changming Front Pharmacol Pharmacology Pterostilbene (PTER) is a kind of stilbene compound with biological activity isolated from plants such as red sandalwood, blueberry and grape. It has anti-tumor, anti-bacterial, anti-oxidation and other pharmacological activities. However, the underlying mechanism of the protective effect of PTER on lipopolysaccharide (LPS)-induced acute lung injury (ALI) remained not clarified. In this study, LPS was used to establish a mouse model of ALI. Bronchoalveolar lavage fluid (BALF) was collected for inflammatory cells, and the wet-to-dry weight ratio of the lungs was measured. The activities of myeloperoxidase (MPO), antioxidant indexes such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) and oxidation index such as malondialdehyde (MDA) in lung tissues of mice were measured by the corresponding kits. The levels of Cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), TNF-α, IL-6 and IL-1β in lung tissues of mice were detected by quantitative real-time polymerase chain reaction (qRT-PCR). The activities of Nrf2, HO-1, p-p65 and p-IκB were determined by western blotting. The results showed that the model of LPS-induced ALI was successfully replicated, and it was found that PTER could significantly improve the pathological degree of ALI such as sustained the integrity of the lung tissue structure, alleviated pulmonary interstitial edema and alveolar wall thickening, reduced infiltrated inflammatory cells. PTER could decrease the number of inflammatory cells and obviously inhibit the increase of W/D ratio caused by LPS. PTER could also significantly reduce LPS-induced MPO and MDA, and increase LPS-decreased SOD, CAT and GSH-Px in the lungs. In addition, it was also found that PTER has the ability to decrease LPS-induced production of COX-2, iNOS, TNF-α, IL-6 and IL-1β. The underlying mechanism involved in the protective effect of PTER on ALI were via activating Nrf2 and HO-1, and inhibiting the phosphorylation of p65 and IκB. These results suggested that PTER can protect LPS-induced ALI in mice by inhibiting inflammatory response and oxidative stress, which provided evidence that PTER may be a potential therapeutic candidate for LPS-induced ALI intervention. Frontiers Media S.A. 2021-01-29 /pmc/articles/PMC7901969/ /pubmed/33633565 http://dx.doi.org/10.3389/fphar.2020.591836 Text en Copyright © 2021 Zhang, Han, Jiang, Wu, Li, Liu, Wei, Yang and Guo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhang, Yong
Han, Zhen
Jiang, Aimin
Wu, Di
Li, Shuangqiu
Liu, Ziyi
Wei, Zhengkai
Yang, Zhengtao
Guo, Changming
Protective Effects of Pterostilbene on Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting NF-κB and Activating Nrf2/HO-1 Signaling Pathways
title Protective Effects of Pterostilbene on Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting NF-κB and Activating Nrf2/HO-1 Signaling Pathways
title_full Protective Effects of Pterostilbene on Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting NF-κB and Activating Nrf2/HO-1 Signaling Pathways
title_fullStr Protective Effects of Pterostilbene on Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting NF-κB and Activating Nrf2/HO-1 Signaling Pathways
title_full_unstemmed Protective Effects of Pterostilbene on Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting NF-κB and Activating Nrf2/HO-1 Signaling Pathways
title_short Protective Effects of Pterostilbene on Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting NF-κB and Activating Nrf2/HO-1 Signaling Pathways
title_sort protective effects of pterostilbene on lipopolysaccharide-induced acute lung injury in mice by inhibiting nf-κb and activating nrf2/ho-1 signaling pathways
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901969/
https://www.ncbi.nlm.nih.gov/pubmed/33633565
http://dx.doi.org/10.3389/fphar.2020.591836
work_keys_str_mv AT zhangyong protectiveeffectsofpterostilbeneonlipopolysaccharideinducedacutelunginjuryinmicebyinhibitingnfkbandactivatingnrf2ho1signalingpathways
AT hanzhen protectiveeffectsofpterostilbeneonlipopolysaccharideinducedacutelunginjuryinmicebyinhibitingnfkbandactivatingnrf2ho1signalingpathways
AT jiangaimin protectiveeffectsofpterostilbeneonlipopolysaccharideinducedacutelunginjuryinmicebyinhibitingnfkbandactivatingnrf2ho1signalingpathways
AT wudi protectiveeffectsofpterostilbeneonlipopolysaccharideinducedacutelunginjuryinmicebyinhibitingnfkbandactivatingnrf2ho1signalingpathways
AT lishuangqiu protectiveeffectsofpterostilbeneonlipopolysaccharideinducedacutelunginjuryinmicebyinhibitingnfkbandactivatingnrf2ho1signalingpathways
AT liuziyi protectiveeffectsofpterostilbeneonlipopolysaccharideinducedacutelunginjuryinmicebyinhibitingnfkbandactivatingnrf2ho1signalingpathways
AT weizhengkai protectiveeffectsofpterostilbeneonlipopolysaccharideinducedacutelunginjuryinmicebyinhibitingnfkbandactivatingnrf2ho1signalingpathways
AT yangzhengtao protectiveeffectsofpterostilbeneonlipopolysaccharideinducedacutelunginjuryinmicebyinhibitingnfkbandactivatingnrf2ho1signalingpathways
AT guochangming protectiveeffectsofpterostilbeneonlipopolysaccharideinducedacutelunginjuryinmicebyinhibitingnfkbandactivatingnrf2ho1signalingpathways